OBJECTIVE: To identify predictors of 30-day all-cause mortality for patients with cardiogenic shock secondary to acute coronary syndrome (ACS-CS) who require short-term mechanical circulatory support (ST-MCS). BACKGROUND: ACS-CS mortality is high. ST-MCS is an attractive treatment option for hemodynamic support and stabilization of deteriorating patients. Mortality prediction modeling for ACS-CS patients requiring ST-MCS has not been well-defined. METHODS: The Utah Cardiac Recovery (UCAR) Shock database was used to identify patients admitted with ACS-CS requiring ST-MCS devices between May 2008 and August 2018. Pre-ST-MCS clinical, laboratory, echocardiographic, and angiographic data were collected. The primary endpoint was 30-day all-cause mortality. A weighted score comprising of pre-ST-MCS variables independently associated with 30-day all-cause mortality was derived and internally validated. RESULTS: A total of 159 patients (mean age, 61 years; 78% male) were included. Thirty-day all-cause mortality was 49%. Multivariable analysis resulted in four independent predictors of 30-day all-cause mortality: age, lactate, SCAI CS classification, and acute kidney injury. The model had good calibration and discrimination (area under the receiver operating characteristics curve 0.80). A predictive score (ranging 0-4) comprised of age ≥ 60 years, pre-ST-MCS lactate ≥2.5 mmol/L, AKI at time of ST-MCS implementation, and SCAI CS stage E effectively risk stratified our patient population. CONCLUSION: The ACS-MCS score is a simple and practical predictive score to risk-stratify CS secondary to ACS patients based on their mortality risk. Effective mortality risk assessment for ACS-CS patients could have implications on patient selection for available therapeutic strategy options.
OBJECTIVE: To identify predictors of 30-day all-cause mortality for patients with cardiogenic shock secondary to acute coronary syndrome (ACS-CS) who require short-term mechanical circulatory support (ST-MCS). BACKGROUND: ACS-CS mortality is high. ST-MCS is an attractive treatment option for hemodynamic support and stabilization of deteriorating patients. Mortality prediction modeling for ACS-CS patients requiring ST-MCS has not been well-defined. METHODS: The Utah Cardiac Recovery (UCAR) Shock database was used to identify patients admitted with ACS-CS requiring ST-MCS devices between May 2008 and August 2018. Pre-ST-MCS clinical, laboratory, echocardiographic, and angiographic data were collected. The primary endpoint was 30-day all-cause mortality. A weighted score comprising of pre-ST-MCS variables independently associated with 30-day all-cause mortality was derived and internally validated. RESULTS: A total of 159 patients (mean age, 61 years; 78% male) were included. Thirty-day all-cause mortality was 49%. Multivariable analysis resulted in four independent predictors of 30-day all-cause mortality: age, lactate, SCAI CS classification, and acute kidney injury. The model had good calibration and discrimination (area under the receiver operating characteristics curve 0.80). A predictive score (ranging 0-4) comprised of age ≥ 60 years, pre-ST-MCS lactate ≥2.5 mmol/L, AKI at time of ST-MCS implementation, and SCAI CS stage E effectively risk stratified our patient population. CONCLUSION: The ACS-MCS score is a simple and practical predictive score to risk-stratify CS secondary to ACS patients based on their mortality risk. Effective mortality risk assessment for ACS-CS patients could have implications on patient selection for available therapeutic strategy options.
Authors: Harold L Dauerman; Thomas J Ryan; Winthrop D Piper; Mirle A Kellett; Samuel J Shubrooks; John F Robb; Michael J Hearne; Matthew W Watkins; Bruce D Hettleman; M Theodore Silver; Nathaniel W Niles; David J Malenka Journal: J Invasive Cardiol Date: 2003-07 Impact factor: 2.022
Authors: Mir B Basir; Theodore L Schreiber; Cindy L Grines; Simon R Dixon; Jeffrey W Moses; Brijeshwar S Maini; Akshay K Khandelwal; E Magnus Ohman; William W O'Neill Journal: Am J Cardiol Date: 2016-12-18 Impact factor: 2.778
Authors: David A Baran; Cindy L Grines; Steven Bailey; Daniel Burkhoff; Shelley A Hall; Timothy D Henry; Steven M Hollenberg; Navin K Kapur; William O'Neill; Joseph P Ornato; Kelly Stelling; Holger Thiele; Sean van Diepen; Srihari S Naidu Journal: Catheter Cardiovasc Interv Date: 2019-05-19 Impact factor: 2.692
Authors: Dagmar M Ouweneel; Erlend Eriksen; Krischan D Sjauw; Ivo M van Dongen; Alexander Hirsch; Erik J S Packer; M Marije Vis; Joanna J Wykrzykowska; Karel T Koch; Jan Baan; Robbert J de Winter; Jan J Piek; Wim K Lagrand; Bas A J M de Mol; Jan G P Tijssen; José P S Henriques Journal: J Am Coll Cardiol Date: 2016-10-31 Impact factor: 24.094
Authors: Lloyd W Klein; Richard E Shaw; Ronald J Krone; Ralph G Brindis; H Vernon Anderson; Peter C Block; Charles R McKay; Kathleen Hewitt; William S Weintraub Journal: Am J Cardiol Date: 2005-07-01 Impact factor: 2.778
Authors: Dirk von Lewinski; Lukas Herold; Christian Stoffel; Sascha Pätzold; Friedrich Fruhwald; Siegfried Altmanninger-Sock; Ewald Kolesnik; Markus Wallner; Peter Rainer; Heiko Bugger; Nicolas Verheyen; Ursula Rohrer; Martin Manninger-Wünscher; Daniel Scherr; Dietmar Renz; Ameli Yates; Andreas Zirlik; Gabor G Toth Journal: Catheter Cardiovasc Interv Date: 2022-07-13 Impact factor: 2.585